Nabumetone
- Product NDC
- 72789-040
- 11-digit product format
- 727890040
- Labeler code
- 72789
- Product ID
- 72789-040_2d58d9e0-467c-80cb-e063-6394a90afc22
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nabumetone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA078420
- Marketing category
- ANDA
- Marketing start
- 2019-06-26
- Substance
- NABUMETONE
- Active strength
- 750 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Nabumetone
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NABUMETONE | 750 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | LW0TIW155Z |
| Rxcui | 311893 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72789-040-30 | Nabumetone | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 12 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72789-040 | NABUMETONE TABLET [PD-RX PHARMACEUTICALS, INC.] | 12 | Current NDC, Legacy NDC, 1 package rows | 20250206_69620c53-b37a-45b9-b560-221bbcd98fda.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72789-040-30 | 72789004030 | 30 TABLET in 1 BOTTLE, PLASTIC (72789-040-30) | 30 tablet | 2019-12-17 | 0000-00-00 | No | No | Current |